Daily Trade News

Dow Jones Lags, Apple Pops; Moderna Dives As CDC Muses Booster Shots;


The Dow Jones Industrial Average lagged the Nasdaq, even as it inched higher. Moderna (MRNA) and BioNTech (BNTX) took a dive as a CDC panel examined Covid vaccine booster shots. Meanwhile, Apple (AAPL) was the top blue chip, and Facebook (FB) passed a buy point.




X



A number of other stocks tried to break out. Leaderboard stock MercadoLibre (MELI), Matson (MATX) and Verve Therapeutics (VERV) all moved above buy points.

Nasdaq Gains As Growth Stocks Lead

The Nasdaq was the leading major index, rising 1%. PayPal (PYPL) was the top performer, the Long-Term Leader rising almost 4% amid reports it is looking into offering a stock-trading platform to U.S. customers.

The S&P 500 also fared well, posting a gain of 0.6%. Occidental Petroleum (OXY) was the big winner here, rising almost 7%.

The S&P sectors were nearly all making gains, with technology and consumer discretionary leading. Energy and financials were the only areas in the red.

U.S. Stock Market Today Overview

Index Symbol Price Gain/Loss % Change
Dow Jones (0DJIA) 35445.20 -10.60 -0.03
S&P 500 (0S&P5) 4535.02 +25.65 +0.57
Nasdaq (0NDQC ) 15281.49 +151.99 +1.00
Russell 2000 (IWM) 225.71 -0.70 -0.31
IBD 50 (FFTY) 48.64 +0.64 +1.33
Last Update: 2:54 PM ET 8/30/2021

Small caps were lagging amid the weakness in financials. The Russell 2000 fell about 0.3%.

Growth stocks were surging higher however, with the Innovator IBD 50 ETF (FFTY) powering up 1.3%.

Dow Jones Today: Apple Stock Pops, AXP Lags

The Dow Jones Industrial Average was lagging the other major indexes, and actually turned slightly negative.

Apple stock was the top stock on the Dow Jones today, rising about 3%. The stock is currently in a buy zone from a 148.00 entry.

The company is gearing up for the iPhone 13 launch next month, while an Apple electric vehicle is also rumored to be in the works.

American Express was the biggest laggard meanwhile, falling more than 2%. It was the day’s biggest loser on the Dow, with Goldman Sachs (GS) the next worst performer.

Moderna Stock, BioNTech Lag As CDC Muses Covid Vaccine Boosters

Moderna stock and BioNTech stock tumbled as medical experts met to weigh the risks and benefits of the White House’s plan to push Covid vaccine booster shots.

The Centers for Disease Control Advisory Committee on Immunization Practices is meeting today with a view to making an official recommendation on whether the U.S. should start administering booster shots.

The Biden administration hopes to start booster shots on Sept. 20, and CDC backing is key.

Moderna stock was down about 3% on the stock market today. It recently hit a peak of 497.49 on Aug. 6, but the vaccine stock has dropped off recently. It well clear of its 50-day line however.

BioNTech has also been falling, following a strong run which saw it peak at 464 on Aug. 10. The stock was down more than 3% for the day.

Pfizer (PFE) was faring better, posting a mild gain, while Johnson & Johnson (JNJ) was up about…



Read More: Dow Jones Lags, Apple Pops; Moderna Dives As CDC Muses Booster Shots;